Orteca, G.; Pisaneschi, F.; Rubagotti, S.; Liu, T.W.; Biagiotti, G.; Piwnica-Worms, D.; Iori, M.; Capponi, P.C.; Ferrari, E.; Asti, M.
Development of a Potential Gallium-68-Labelled Radiotracer Based on DOTA-Curcumin for Colon-Rectal Carcinoma: From Synthesis to In Vivo Studies. Molecules 2019, 24, 644.
https://doi.org/10.3390/molecules24030644
AMA Style
Orteca G, Pisaneschi F, Rubagotti S, Liu TW, Biagiotti G, Piwnica-Worms D, Iori M, Capponi PC, Ferrari E, Asti M.
Development of a Potential Gallium-68-Labelled Radiotracer Based on DOTA-Curcumin for Colon-Rectal Carcinoma: From Synthesis to In Vivo Studies. Molecules. 2019; 24(3):644.
https://doi.org/10.3390/molecules24030644
Chicago/Turabian Style
Orteca, Giulia, Federica Pisaneschi, Sara Rubagotti, Tracy W. Liu, Giacomo Biagiotti, David Piwnica-Worms, Michele Iori, Pier Cesare Capponi, Erika Ferrari, and Mattia Asti.
2019. "Development of a Potential Gallium-68-Labelled Radiotracer Based on DOTA-Curcumin for Colon-Rectal Carcinoma: From Synthesis to In Vivo Studies" Molecules 24, no. 3: 644.
https://doi.org/10.3390/molecules24030644
APA Style
Orteca, G., Pisaneschi, F., Rubagotti, S., Liu, T. W., Biagiotti, G., Piwnica-Worms, D., Iori, M., Capponi, P. C., Ferrari, E., & Asti, M.
(2019). Development of a Potential Gallium-68-Labelled Radiotracer Based on DOTA-Curcumin for Colon-Rectal Carcinoma: From Synthesis to In Vivo Studies. Molecules, 24(3), 644.
https://doi.org/10.3390/molecules24030644